Form 4 for PMVP PMV Pharmaceuticals, Inc.
Accepted 2021-08-04 00:00:00 ET · period of report 2021-08-03 · accession 0001209191-21-049724 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-04 | 2021-08-03 | PMVP | Kung Winston | COO, CFO | M - OptEx | $3.22 | +4,500 | 6,100 | +281% | +$14.5K |
| D | 2021-08-04 | 2021-08-03 | PMVP | Kung Winston | COO, CFO | S - Sale+OE | $33.82 | -4,500 | 1,600 | -74% | -$152.2K |
| D | 2021-08-04 | 2021-08-03 | PMVP | Kung Winston | COO, CFO | M - OptEx | $0.00 | -4,500 | 219.0K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-03 | M | A | 4,500 | $3.22 | 6,100 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-03 | S | D | 4,500 | $33.82 | 1,600 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.75 to $34.74, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
| 3 | Derivative | Stock Option (right to buy) | 2021-08-03 | M | D | 4,500 | $0.00 | 219,034 | D | $3.22 · — to 2028-02-21 | 4,500 Common Stock | (F3) The option is subject to an early exercise provision and is immediately exercisable. The underlying shares vest in accordance with the terms of the option grant. |